Eric Rambeaux

Founder and CEO @e4e6Consulting
Passionate about #biotech #medicaldevices & new technologies applied to #healthcare #medtech #ehealth #digitalhealth #fintech

[e4e6 Consulting @e4e6Consulting]

En France, les autorités de santé (@HAS_sante ) ouvrent la voie au remboursement du @Wegovy dans des cas d’obésité sévère (BMI > 35)

Cool!! Et maintenant on discute du prix? 😇

#obesité #Wegovy #cardiovasculaire #diabete #T2DM

https://t.co/QlZOt7Xmz7

[Eric Rambeaux @ERambeaux]

Indeed! Don't we need an @elonmusk in Europe as well????

#Innovation drives the future and we keep regulating in #Europe...

#biotech #medtech #DiGiTALhealth

[e4e6 Consulting @e4e6Consulting]

Excellent edito dans @LesEchos ce matin.
En nous, en #Europe, on fait quoi? On régule pendant que les Chinois copient (en fait, ils copient de moins en moins et innovent de plus en plus).

#Musk @elonmusk #biotech #medtech #Innovation

https://t.co/uemvZhwVSg

[Eric Rambeaux @ERambeaux]

2024 has been a "graveyard" year for #Biotech du to the lack of #investments. #2025 could be worse if #entrepreneurs , #VentureCapital firms and #governements do not aknowlege that US situation is what it is and this is in their to act...or die.
#medtech #Innovation #healthcare

[e4e6 Consulting @e4e6Consulting]

New Article Published on our website: @RobertKennedyJras U.S. Secretary of Health: An Additional Threat to #Biotech Investment?

https://t.co/06aMdSNsl6

#medtech #VentureCapital #innovation #healthcare

[Eric Rambeaux @ERambeaux]

Always starting my #university courses with this point. It is of primary importance. !!
Please read and feel free to comment

#Geopolitics #GlobalStrategy #USElection2024 #InternationalBusiness #Corporate

[e4e6 Consulting @e4e6Consulting]

Boundaries blur between business & politics: for #CEOs, Understanding geopolitical dynamics is no longer a luxury for CEOs: it's a must.
Read our lastest insight

#Geopolitics #USElection2024 #internationalexpansion

https://t.co/l4vZBcTRY1

[Eric Rambeaux @ERambeaux]

As former #biotech & #medtech CEO, I am concerned to see @Bpifrance pouring money in @Opella while innovative start ups are dying.

This may not be @NicolasDufourcq full decision but a real concern anyway....

#Innovation

[e4e6 Consulting @e4e6Consulting]

@sanofi / #Doliprane drama: are the politicians and media concerned about the right thing?

Concern should be : Why is @Bpifrance pouring money there? This should raise concerns from the ecosystem as start up are dying daily.

#biotech

https://t.co/IV2STctsrM

[Eric Rambeaux @ERambeaux]

Is @ImplicityHealth approval by the @HAS_sante
the strategic inflection point we were waiting for to broaden telemedicine landscape? Could very well be. Congrats to the team

#MEDTECH #AI #telemedecine #esante

[e4e6 Consulting @e4e6Consulting]

@ImplicityHealth' s @HAS_sante approval marks a strategic shift in #telemedicine. AI-driven, universal platforms will be key to managing #chronicdiseases With better outcomes & lower costs, this sets the stage for future healthcare innovations.
#MEDTECH

https://t.co/8VXJ9dPGLs

[e4e6 Consulting @e4e6Consulting]

@ImplicityHealth' s @HAS_sante approval marks a strategic shift in #telemedicine. AI-driven, universal platforms will be key to managing #chronicdiseases With better outcomes & lower costs, this sets the stage for future healthcare innovations.
#MEDTECH

https://t.co/8VXJ9dPGLs

[Eric Rambeaux @ERambeaux]

Looking forward to help again companies from #Japan being successful in #Europe

@e4e6Consulting #BusinessExpansion #NewMarkets #Consulting #GrowthOpportunities

[e4e6 Consulting @e4e6Consulting]

Our passion for #Japan runs deep. Today, we’re thrilled to announce the launch of our Japanese-language page website! 🇯🇵

An exciting step in making it easier for our Japanese clients to access our expertise & learn how we can help them succeed in EU

https://t.co/fK2CFUiIHo

[Biotech Investor @learnbiotech]

When looking at companies with novel modalities, like cell therapy, investors need to pay even more attention to manufacturing & CMC

There are not a lot of experts with these modalities & that matters to regulators

#learnbiotechinvesting #biotech #investing #BiotechPrometheus

[Eric Rambeaux @ERambeaux]

#Japan is a fascinating country which is close to my heart and unique in so many manners. Please read and share your views.

#entrepreneurship #internationalization #entrepreneurs

[e4e6 Consulting @e4e6Consulting]

From Soft Power to #startups : How #Japan Captivates French #entrepreneurs
https://t.co/G6OUGbSY0i
Please read this interesting perspective just freshly published on our website.

#entrepreneurship #internationalization

[Biotech Investor @learnbiotech]

Investors should be aware of where the competition is in development

Here's the expected launch timeline of the major late-stage #obesity drugs

$LLY & $NVO can expect first competitor approval in 2026

#learnbiotechinvesting #biotech #investing #BiotechPrometheus

[Eric Rambeaux @ERambeaux]

@Victoire025 @GabLattanzio @_SidiSalim Si c'est quantifiable (un très simple calcul de compta analytique). Je me suis "amusé" à faire le calcul pour moi et on se rapproche de ces chiffres. Quand on est salarié, on s'en fiche mais qd on est indépendant on fait le calcul. Heureusement, je ne fais pas cela pour l'argent.

[e4e6 Consulting @e4e6Consulting]

A very interesting perspective on #Investment in #Oncology

#biotech #Innovations

[Eric Rambeaux @ERambeaux]

Honored the @e4e6consulting has been accepted in the community.

Looking forward to upcoming discussions with the members!!

#biotech #MEDTECH #esante #HealthTech #ehealth

[e4e6 Consulting @e4e6Consulting]

@e4e6Consulting is happy to announce that it is now part of @FranceBiotech

We are looking forward to meet new people and contribute to the success of the French #HealthTech ecosystem.

#Biotech #medtech #esanté #ehealth #Healthtech

[e4e6 Consulting @e4e6Consulting]

BREAKING NEWS: @Biogaran will remain French. @ServierPharma will not divest it #generic drugs affiliate!! This is great news for #France, for #Europe, and ultimately for the #patients!!

#pharmaceuticals #genericdrugs

https://t.co/NI74vNxGAn

[Eric Rambeaux @ERambeaux]

I sincerely hope that #pharmaceutical industry and #investors will give a chance to some good projects around here in this field

#BiotechStartups #biotechs #Innovations #Cancer #Oncology

[e4e6 Consulting @e4e6Consulting]

Immuno-oncology has a lot more to bring to patients but #pharmaceutical industry and #investors have to believe in it and support...

#BiotechStartups #biotechs #Cancer #Oncology #Innovations

[Eric Rambeaux @ERambeaux]

I just hope that whoever runs the country, they will discard these 🤬options

#biotech #MedTech #Innovation #HealthTech

[e4e6 Consulting @e4e6Consulting]

Making the French CIR (Research Tax Credit) more difficult & cancelling the support to young #PhD employement? It is really what the new French to-be-appointed governement want to insure French research remains at the top?

#biotech #MedTech #Innovation

https://t.co/3Q0Imv1lz5

[Eric Rambeaux @ERambeaux]

Indeed! Feel free to come back to us with comments or questions

#consulting #biotech #MEDTECH #Fintech #internationalexpansion #internationalisation

[e4e6 Consulting @e4e6Consulting]

As part of the launch of its updated website, e4e6 has added a new section: #publication
Food for thoughts in the fields of #international expansion, #biotech, #MEDTECH , #Fintech , #videogames and much more to come. Stay Tuned!!

https://t.co/G6OUGbSY0i

[Eric Rambeaux @ERambeaux]

Whether you are a #Biotech #medtech #ehealth or #fintech please contact @e4e6Consulting so we can discuss how best help you reaching your objectives

[e4e6 Consulting @e4e6Consulting]

Our new website is launched!
If you need help for #international expansion, #strategic, #operational or #transaction support, please our site and contact us to discuss your needs

#Biotech #medtech #ehealth #fintech

https://t.co/x8Rb3izjGu

[Eric Rambeaux @ERambeaux]

Having led an immuno oncology #startup , I feel sad about this trend as this is an area that still has a lot to offer to #patients

#Immunotherapy #Oncology #Cancer #Biotechnology #Biotech #CancerResearch

[e4e6 Consulting @e4e6Consulting]

We recently posted about @genentech dropping #Immunotherapy in #Oncology . Now this is turn of @PierreFabre who divest its R&D center.
Trends come and Trend goes....

#Biotech #Cancer #CancerResearch #antibodies

https://t.co/8LJaBhxfYB